Health
Identifying Platinum Chemotherapy Resistance in Patients With Ovarian Cancer – Technology Networks
Researchers have discovered a way to predict which patients with ovarian cancer are resistant to platinum chemotherapy.
Epithelial ovarian cancer (EOC) is the most common lethal gynaecological cancer. Ovarian cancer is usually treated with platinum-based chemotherapy; however, a significant number of patients are resistant to such treatments and relapse soon afterwards. To improve their survival, there is a need to first identify which patients may be platinum-resistant, so that newer treatments may be administered early.
Now, researchers from the Cancer Science Institute of Singapore (CSI Singapore) at the National…
-
General11 hours agoAustralian celebrity chef Peter Russell-Clarke dies aged 89
-
Noosa News20 hours agoRainbow Beach surfer’s untold 7/7 story
-
Noosa News11 hours agoWoman airlifted to Brisbane hospital after big cat mauling at south-east Queensland zoo near Toowoomba
-
Noosa News10 hours agoUnvaccinated horse dies from Hendra virus as Queensland records first case in three years